C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2006
12/21/2006	US20060287371 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R,7S,8R,9R,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents
12/21/2006	US20060287370 Isoindolinone kinase inhibitors
12/21/2006	US20060287369 Diarylmethyl and related compounds
12/21/2006	US20060287328 Fungicides; pest control; 1-Dimethyl-3-(2'-nitro)phenyl-silacyclohexene-2; Trans-1-(2'trifluoromethylsulfonyloxy-phenyl)-2-trimethylsilyl-cyclopropane
12/21/2006	US20060287308 3-Aminoquinazolin-2,4-dione antibacterial agents
12/21/2006	US20060287306 Compounds to treat alzheimer's disease
12/21/2006	US20060287304 Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient
12/21/2006	US20060287303 Modulators of muscarinic receptors
12/21/2006	US20060287302 Mitotic kinesin inhibitors
12/21/2006	US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/21/2006	US20060287295 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
12/21/2006	US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction
12/21/2006	US20060287290 Azabicyclic compounds are central nervous system active agents
12/21/2006	CA2611562A1 Trisubstituted amines as phosphodiesterase 4 inhibitors
12/21/2006	CA2611443A1 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
12/21/2006	CA2610903A1 N-(pyridin-2-yl)-sulfonamide derivatives
12/20/2006	EP1734041A2 Platelet ADP receptor inhibitors
12/20/2006	EP1734040A1 Substituted quinazoline or pyridopyrimidine derivative
12/20/2006	EP1732920A2 Thiophene derivatives as chk 1 inhibitors
12/20/2006	EP1732919A1 Substituted thiophene derivatives as anti-cancer agents
12/20/2006	EP1732918A1 Novel pyrrolidine-3,4-dicarboxamide derivatives
12/20/2006	EP1732906A1 2-aminothiazole compounds useful as aspartyl protease inhibitors
12/20/2006	EP1732905A1 2-aminomethylthiazole-5-carboxamides as protein kinase modulators
12/20/2006	EP1732903A1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
12/20/2006	EP1732896A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
12/20/2006	EP1732895A2 Insecticidal n-substituted sulfoximines
12/20/2006	EP1732892A1 Tetrahydrocarbazoles and derivatives
12/20/2006	EP1732564A1 Biaryl substituted pyrazinones as sodium channel blockers
12/20/2006	EP1732385A1 Use of (3-(1-(3-phenyl-propenyl)-piperidin-4-yl)-2,3-dihydro-indol-1-yl)-(pyridin-4-yl)-methanone derivatives and related compounds as insecticides
12/20/2006	EP1622610B1 1-(2h-pyrazol-3-yl)-3-{4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl}-urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations
12/20/2006	EP1441726B1 Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny]-valerian- acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors
12/20/2006	EP1305308B1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
12/20/2006	EP1263729B1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/20/2006	CN1882581A Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
12/20/2006	CN1882578A 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
12/20/2006	CN1882576A 喹唑啉衍生物 Quinazoline derivatives
12/20/2006	CN1882573A Quinazoline derivatives as tyrosine kinase inhibitors
12/20/2006	CN1882572A Quinazoline derivatives as antitumor agents
12/20/2006	CN1882568A Pyrrol derivatives with antibacterial activity
12/20/2006	CN1882565A Novel piperidine-substituted indoles-or hetero-derivatives thereof and their use as modulators of chemokine receptor (CCR-3)
12/20/2006	CN1882560A Heterocompound and its production and usage method
12/20/2006	CN1882556A Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
12/20/2006	CN1882555A 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
12/20/2006	CN1882553A Phenylacetic acid derivative, process for producing the same, and use
12/20/2006	CN1882542A 2-pyridone derivatives as neutrophil elastase inhibitors and their use
12/20/2006	CN1880308A Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents
12/19/2006	US7151182 Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives
12/19/2006	US7151180 3-((hetero)arylthio)-1,2-dihydroquinolin-2-ones such as 3-[(4-aminophenyl)thio]-4-(5-chloro-2-hydroxyphenyl)-6-(trifluoromethyl)-2(1H)-quinoline; erectile dysfunction and irritable bowel syndrome
12/19/2006	US7151102 Phthalazinone derivatives
12/19/2006	US7151098 Glutamate receptor antagonists
12/14/2006	WO2006133459A1 Indane derivatives as modulators of ion channels
12/14/2006	WO2006133426A2 Compositions and methods for inhibition of the jak pathway
12/14/2006	WO2006133417A1 Phenylamino isothiazole carboxamidines as mek inhibitors
12/14/2006	WO2006133381A2 (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,4,6-trichlorophenyl)amino]-1,3-thiazol-4(5h)-one
12/14/2006	WO2006133326A1 Inhibitors of hcv replication
12/14/2006	WO2006132438A1 1,3-benzothiazinone derivative and use thereof
12/14/2006	WO2006132436A1 Heterocyclic compound
12/14/2006	WO2006132295A1 Regulator of aldosterone receptor
12/14/2006	WO2006132197A1 HETEROCYCLIC COMPOUND HAVING TYPE I 11β HYDROXYSTEROID DEHYDROGENASE INHIBITORY ACTIVITY
12/14/2006	WO2006132192A1 Novel 2-quinolone derivative
12/14/2006	WO2006131303A2 Peptide deformylase (pdf) inhibitors 4
12/14/2006	WO2006130986A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/14/2006	WO2006110884A8 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
12/14/2006	WO2006084017A3 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
12/14/2006	WO2006073589A3 Cycloalkyl keto piperidine tachykinin receptor antagonists
12/14/2006	WO2006066079A3 Pyridazinone compounds
12/14/2006	US20060281798 Methods of using thiazolidinedithione derivatives
12/14/2006	US20060281796 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/14/2006	US20060281784 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/14/2006	US20060281774 Pyrimidine derivatives for the treatment of abnormal cell growth
12/14/2006	US20060281756 Synthesis of 3-amino-4-substituted pyrazole derivatives
12/14/2006	US20060281743 Isoquinolinone potassium channel inhibitors
12/14/2006	US20060281741 Therapy for bacteria infections other than Myconacterium infections; antibiotic resistance
12/14/2006	US20060281740 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; biphenyl carbamic acid, piperidinyl ester derivatives
12/14/2006	US20060281738 2-Naphthylimino-1,3-thiazine derivative
12/14/2006	US20060281736 Product comprising at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent
12/14/2006	US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease
12/14/2006	US20060281733 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring
12/14/2006	US20060281728 3-Substituted beta-lactamyl vasopressin v1a antagonists
12/14/2006	US20060281711 2-Morpholin-4-yl-6-(2-morpholin-4-yl-ethoxy)-pyrimidine-4-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide; rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or immune-mediated diabetes mellitus
12/14/2006	DE102005026231A1 Peptid-Deformylase (PDF) Inhibitoren 3 Peptide deformylase (PDF) inhibitors 3
12/14/2006	DE102005014936A1 New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders
12/14/2006	CA2611731A1 Indane derivatives as modulators of ion channels
12/14/2006	CA2610655A1 Cyclobutyl amine derivatives
12/14/2006	CA2610304A1 Peptide deformylase (pdf) inhibitors 4
12/14/2006	CA2610196A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/14/2006	CA2610172A1 Heterocyclic compound
12/14/2006	CA2608367A1 Compositions and methods for inhibition of the jak pathway
12/13/2006	EP1731513A1 Phenoxyacetic acid derivative and medicine containing the same
12/13/2006	EP1731512A1 Isoxazoline-substituted benzamide compound and noxious organism control agent
12/13/2006	EP1730166A2 Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis c viral infections
12/13/2006	EP1730165A1 Inhibitors of hepatitis c virus ns3 protease
12/13/2006	EP1730142A1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
12/13/2006	EP1730138A1 Epothilone derivatives
12/13/2006	EP1730136A1 N-piperidine derivates as ccr3 modulators
12/13/2006	EP1730128A1 Anaplastic lymphoma kinase modulators and methods of use
12/13/2006	EP1730124A1 Certain triazole-based compounds, compositions, and uses thereof
12/13/2006	EP1730122A2 Pyrimidine derivatives and methods of treatment related to the use thereof
12/13/2006	EP1730119A1 Imidazole compounds for the treatment of neurodegenerative disorders
12/13/2006	EP1730118A1 Substituted azole derivatives, compositions, and methods of use

1 ... 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 ... 628